Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration
Anton Camaj(Columbia University Irving Medical Center), Roxana Mehran(Mount Sinai Hospital), David Power(Cardiovascular Institute of the South), Gregg W. Stone(Cardiovascular Institute of the South), Gennaro Giustino(Cardiovascular Institute of the South), Stephan Windecker(University of Bern), George Dangas(Mount Sinai Hospital), Usman Baber(Icahn School of Medicine at Mount Sinai), Bimmer E. Claessen(Columbia University Irving Medical Center), Melissa Aquino(Cardiovascular Institute of the South), Samantha Sartori(Icahn School of Medicine at Mount Sinai)
Cited by 17
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k